FACA

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 73519 - Presidential Commission for the Study of Bioethical Issues - Presidential

GENERAL INFORMATION

Committee Name	Presidential Commission for the Study of Bioethical Issues	Agency Name	Department of Health and Human Services
Fiscal Year	2017	Committee Number	73519
Original Establishment Date	11/24/2009	Committee Status	Terminated
Actual Termination Date	9/30/2017	Committee URL
New Committee This FY	No	Presidential Appointments*	Yes
Terminated This FY	Yes	Max Number of Members*	13
Current Charter Date	3/10/2016	Designated Fed Officer Position Title*	Vacant
Date Of Renewal Charter	3/10/2018	Designated Federal Officer Prefix
Projected Termination Date	9/30/2017	Designated Federal Officer First Name*
Exempt From Renewal*	No	Designated Federal Officer Middle Name
Specific Termination Authority	EO 13708, dated 9/30/2015	Designated Federal Officer Last Name*	Vacant
Establishment Authority*	Presidential	Designated Federal Officer Suffix
Specific Establishment Authority*	EO 13521	Designated Federal Officer Phone*	Vacant
Effective Date Of Authority*	11/24/2009	Designated Federal Officer Fax*
Exempt From EO 13875 Discretionary Cmte		Designated Federal Officer Email*
Committee Type*	Continuing
Presidential*	Yes
Committee Function*	National Policy Issue Advisory Board

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Continue
Legislation to Terminate Required	No
Legislation Status	Not Applicable
How does cmte accomplish its purpose?*	To accomplish its purpose, the Commission (1) identifies and examines specific bioethical, legal, and social issues related to the potential impacts of advances in biomedical and behavioral research, healthcare delivery, or other areas of science and technology; (2) recommends any legal, regulatory, or policy actions it deems appropriate to address these issues; and (3) critically examines diverse perspectives and explore possibilities for useful international collaboration on these issues.
How is membership balanced?*	The Commission members are drawn from fields of bioethics, science, medicine, technology, engineering, law, philosophy, theology, or other areas of the humanities or social sciences. At least one, and not more than three, members are bioethicists or scientists drawn from the Executive Branch, as designated by the President.
How frequent & relevant are cmte mtgs?*	The Commission meets, at a minimum, four times a year on a quarterly basis. The Chair convenes and presides at the Commission meetings. The meeting agendas are developed by the Chair, in consultation with the Vice Chair and DFO. However, the Commission did not meet in 2017 since the new Presidential Administration did not seek guidance from the Committee.
Why advice can't be obtained elsewhere?*	The advice or information the Commission provides cannot be obtained elsewhere because there is no other source of independent, trans-agency advice on bioethical issues that may emerge as a consequence of advances in biomedicine and related areas of science and technology.
Why close or partially close meetings?	N/A
Recommendation Remarks	The Commission was established by a Presidential directive, Executive Order 13521, dated November 24, 2009. Therefore, appropriate action must be taken by the President or agency head to authorize continuation of the Commission. With Executive Order 13811, dated September 29, 2017, the President did not give authority for the Commission to continue to operate after September 30, 2017. Therefore, the Commission has been terminated, and the website is no longer available.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	Yes	Action Reorganize Priorities*	No
Outcome Trust In Government	Yes	Action Reallocate Resources	No
Outcome Major Policy Changes	Yes	Action Issued New Regulations	No
Outcome Advance In Scientific Research	Yes	Action Proposed Legislation	Yes
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	Yes	Action Other	No
Outcome Increased Customer Satisfaction	No	Action Comment	The administration has proposed revisions to 45 CPR 46 (human subjects protections) using work of the Bioethics Commission to support numerous proposed revisions. The Commission makes broad recommendations for action by both government and non-government entities. We do not receive specific responses to the recommendations.
Outcome Implement Laws/Reg Requirements	Yes	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment	Not Applicable	Number Of Grants Recommended	0
Cost Savings*	Unable to Determine	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	We are unable to determine at this time.	Grants Review Comment	The Commission is not engaged in the review of applications for grants.
Number Of Recommendations*	100	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	During FY 2017, the Commission did not produced any new recommendations.	Access Agency Website	Yes
% of Recs Fully Implemented*	10.00%	Access Committee Website	Yes
% of Recs Fully Implemented Comment	Approximately 10% of the recommendations were judged to have been fully implemented by the agency. However, due to the large breadth and complexity of the recommendations, as well as a lack of enough time passed, it is hard to determine which recommendations have been fully implemented solely in response to the Commission’s activities. Also, a number of recommendations are directed to parties outside the government.	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	67.00%	Access Publications	Yes
% of Recs Partially Implemented Comment	Approximately 67% of the recommendations were judged to have been partially implemented by the agency. However, due to the large breadth and complexity of the recommendations, it is hard to determine which recommendations have been partially implemented solely in response to the Commission’s activities. Also, a number of recommendations are directed to parties outside the government. Some of the “partially” implemented recommendations are deemed so due to their ongoing nature (e.g., ethics education and fostering accountability).	Access Other	No
Agency Feedback*	Not Applicable	Access Comment	NA
Agency Feedback Comment*	Not Applicable	Narrative Description*	The Commission advised the President in accordance with EO 13521 on bioethical issues that may emerge as a consequence of advances in biomedical and related areas of science and technology. The Commission pursued its work with the goal of identifying and promoting policies and practices that ensure scientific research, healthcare delivery, and technological innovation are conducted in an ethically responsible manner.

COSTS

Payments to Non-Federal Members*	$0.00	Est Payments to Non-Fed Members Next FY*	$0.00
Payments to Federal Members*	$0.00	Est. Payments to Fed Members Next FY*	$0.00
Payments to Federal Staff*	$566,017.00	Estimated Payments to Federal Staff*	$0.00
Payments to Consultants*	$0.00	Est. Payments to Consultants Next FY*	$0.00
Travel Reimb. For Non-Federal Members*	$0.00	Est Travel Reimb Non-Fed Members nextFY*	$0.00
Travel Reimb. For Federal Members*	$0.00	Est Travel Reimb For Fed Members*	$0.00
Travel Reimb. For Federal Staff*	$30,000.00	Est. Travel Reimb to Fed Staff Next FY*	$0.00
Travel Reimb. For Consultants*	$10,000.00	Est Travel Reimb to Consultants Next FY*	$0.00
Other Costs	$893,983.00	Est. Other Costs Next FY*	$0.00
Total Costs	$1,500,000.00	Est. Total Next FY*	$0.00
Date Cost Last Modified		Est. Fed Staff Support Next FY*	0.00
Federal Staff Support (FTE)*	6.00	Est Cost Remarks
Cost Remarks

Interest Areas

No interest areas selected for this committee.

Custom Links

Committee Level Reports